Pharmaceuticals
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Go to Pharmaceuticals stock screener
| Ticker | Company | Price / Return |
| ABEO | Abeona Therapeutics Inc | 3.17 (-7.18%) |
| ACIU | AC Immune SA | 2.33 (-2.10%) |
| ACAD | ACADIA Pharmaceuticals Inc | 16.57 (-1.02%) |
| ACST | Acasti Pharma Inc | 2.90 (1.05%) |
| AXDX | Accelerate Diagnostics, Inc | 0.93 (-2.11%) |
| ACHV | Achieve Life Sciences, Inc | 4.53 (0.56%) |
| ACRS | Aclaris Therapeutics, Inc | 1.19 (-2.87%) |
| ADAP | Adaptimmune Therapeutics plc | 1.08 (-4.82%) |
| ADPT | Adaptive Biotechnologies Corporation | 2.59 (0.39%) |
| ADIL | Adial Pharmaceuticals, Inc | 1.72 (1.18%) |
| ADMA | ADMA Biologics, Inc | 6.46 (-1.15%) |
| ADVM | Adverum Biotechnologies, Inc | 10.19 (-7.36%) |
| AEZS | Aeterna Zentaris Inc | 2.01 (1.52%) |
| AEMD | Aethlon Medical, Inc. | 1.50 (-1.96%) |
| AFMD | Affimed | 4.91 (-8.22%) |
| AGEN | Agenus Inc | 7.39 (14.40%) |
| AGIO | Agios Pharmaceuticals, Inc | 31.70 (-0.35%) |
| ALRN | Aileron Therapeutics, Inc | 4.88 (2.74%) |
| AKTX | Akari Therapeutics, Plc | 1.25 (2.46%) |
| AKBA | Akebia Therapeutics, Inc | 1.36 (-0.73%) |
| AKRO | Akero Therapeutics, Inc | 20.24 (-3.62%) |
| ALDX | Aldeyra Therapeutics, Inc | 3.93 (0.51%) |
| ALEC | Alector, Inc | 5.25 (-1.59%) |
| ALIM | Alimera Sciences, Inc | 3.62 (0.84%) |
| ALKS | Alkermes plc | 24.67 (1.69%) |
| ALLK | Allakos Inc | 1.03 (-1.90%) |
| ALLO | Allogene Therapeutics, Inc | 3.04 (-9.94%) |
| ALNY | Alnylam Pharmaceuticals, Inc | 143.82 (-1.54%) |
| ALPN | Alpine Immune Sciences, Inc | 64.58 (0.04%) |
| ALT | Altimmune, Inc | 7.08 (-6.47%) |
| AMRN | Amarin Corporation plc | 0.87 (-0.96%) |
| AMGN | Amgen Inc | 273.05 (-0.18%) |
| FOLD | Amicus Therapeutics, Inc | 10.53 (-1.68%) |
| AMPH | Amphastar Pharmaceuticals, Inc | 41.02 (0.26%) |
| ANAB | AnaptysBio, Inc | 19.22 (0.21%) |
| AVXL | Anavex Life Sciences Corp | 3.40 (-7.61%) |
| ANIP | ANI Pharmaceuticals, Inc | 65.38 (-1.16%) |
| APLS | Apellis Pharmaceuticals, Inc | 49.88 (2.38%) |
| APLT | Applied Therapeutics Inc | 4.29 (-3.92%) |
| APVO | Aptevo Therapeutics Inc | 0.68 (-7.27%) |
| APTO | Aptose Biosciences Inc | 1.21 (-1.63%) |
| AQST | Aquestive Therapeutics, Inc | 3.90 (-8.76%) |
| ABUS | Arbutus Biopharma Corporation | 2.75 (-0.18%) |
| ABIO | ARCA biopharma, Inc | 3.67 (0.55%) |
| ARCT | Arcturus Therapeutics Holdings Inc | 26.98 (-3.42%) |
| ARDX | Ardelyx, Inc | 6.43 (0.70%) |
| ARGX | argenx SE | 375.86 (0.21%) |
| ARRY | Array Technologies, Inc | 12.23 (2.47%) |
| ARWR | Arrowhead Pharmaceuticals, Inc | 23.30 (-2.02%) |
| ASNS | Actelis Networks, Inc | 0.75 (-2.26%) |
| ARVN | Arvinas, Inc | 32.58 (-4.18%) |
| ASND | Ascendis Pharma | 142.97 (-1.28%) |
| ASLN | ASLAN Pharmaceuticals Limited | 0.48 (4.26%) |
| ASMB | Assembly Biosciences, Inc | 13.48 (1.58%) |
| ASRT | Assertio Holdings Inc | 0.86 (-5.08%) |
| ASTC | Astrotech Corporation | 9.32 (0.81%) |
| ATRA | Atara Biotherapeutics, Inc | 0.71 (-1.57%) |
| ATOS | Atossa Therapeutics, Inc | 1.50 (1.01%) |
| LIFE | aTyr Pharma, Inc | 1.59 (-1.54%) |
| AUTL | Autolus Therapeutics plc | 4.22 (-5.80%) |
| AVDL | Avadel Pharmaceuticals plc | 17.66 (-2.40%) |
| ATXI | Avenue Therapeutics, Inc | 0.09 (-29.18%) |
| CDMO | Avid Bioservices, Inc | 6.82 (2.10%) |
| AVRO | AVROBIO, Inc | 1.20 (-1.24%) |
| AXGN | AxoGen, Inc | 6.88 (-1.36%) |
| AXSM | Axsome Therapeutics, Inc | 71.12 (-2.68%) |
| AYTU | Aytu Biopharma, Inc | 2.74 (0.74%) |
| BGNE | BeiGene, Ltd | 144.06 (3.65%) |
| BNTC | Benitec Biopharma Inc | 6.75 (-1.60%) |
| BYSI | BeyondSpring Inc | 2.46 (7.42%) |
| BCRX | BioCryst Pharmaceuticals, Inc | 4.21 (-3.77%) |
| BCYC | Bicycle Therapeutics plc | 22.62 (-0.26%) |
| BIIB | Biogen Inc | 202.10 (4.62%) |
| BLFS | BioLife Solutions, Inc | 17.15 (0.76%) |
| BLRX | BioLineRx Ltd | 0.60 (-6.31%) |
| BMRN | BioMarin Pharmaceutical Inc | 91.20 (-0.93%) |
| BNGO | Bionano Genomics, Inc | 0.77 (-3.64%) |
| BPTH | Bio-Path Holdings, Inc | 2.49 (-7.26%) |
| BSGM | BioSig Technologies, Inc | 1.32 (-10.81%) |
| BTAI | BioXcel Therapeutics, Inc | 2.71 (-8.92%) |
| BLUE | bluebird bio, Inc | 0.93 (-4.57%) |
| BPMC | Blueprint Medicines Corporation | 92.33 (0.04%) |
| BCLI | Brainstorm Cell Therapeutics Inc | 0.53 (1.70%) |
| BBIO | BridgeBio Pharma, Inc | 25.02 (-1.73%) |
| BRKR | Bruker Corporation | 82.15 (-0.38%) |
| CAPR | Capricor Therapeutics, Inc | 5.04 (4.56%) |
| CARA | Cara Therapeutics, Inc | 0.68 (-4.16%) |
| CASI | CASI Pharmaceuticals, Inc | 2.42 (-3.59%) |
| CSTL | Castle Biosciences, Inc | 19.89 (-0.85%) |
| CPRX | Catalyst Pharmaceuticals, Inc | 15.13 (2.72%) |
| CLDX | Celldex Therapeutics, Inc | 36.97 (-2.12%) |
| CLRB | Cellectar Biosciences, Inc | 3.04 (-2.09%) |
| CLLS | Cellectis S.A | 2.53 (-1.56%) |
| CSBR | Champions Oncology, Inc | 5.03 (-0.59%) |
| CKPT | Checkpoint Therapeutics, Inc | 1.44 (0.35%) |
| CMRX | Chimerix, Inc | 0.90 (-2.38%) |
| CDTX | Cidara Therapeutics, Inc | 11.94 (16.49%) |
| CTXR | Citius Pharmaceuticals, Inc | 0.71 (-6.95%) |
| CLSD | Clearside Biomedical, Inc | 1.31 (-4.01%) |
| COHR | Coherent, Inc | 52.11 (-0.46%) |
| CHRS | Coherus BioSciences, Inc | 2.03 (-6.88%) |
| COLL | Collegium Pharmaceutical, Inc | 35.46 (-1.34%) |
| CGEN | Compugen Ltd | 1.92 (-3.28%) |
| CNMD | CONMED Corporation | 69.84 (-2.06%) |
| CRBP | Corbus Pharmaceuticals Holdings, Inc | 35.48 (-5.99%) |
| CORT | Corcept Therapeutics Incorporated | 22.50 (-2.15%) |
| CRVS | Corvus Pharmaceuticals, Inc | 1.58 (3.27%) |
| CRNX | Crinetics Pharmaceuticals, Inc | 43.32 (-2.04%) |
| CRSP | CRISPR Therapeutics AG | 55.62 (-1.40%) |
| CPIX | Cumberland Pharmaceuticals Inc | 1.61 (-3.01%) |
| CRIS | Curis, Inc | 14.71 (-2.03%) |
| CUTR | Cutera, Inc | 1.97 (-8.37%) |
| CYCC | Cyclacel Pharmaceuticals, Inc | 2.30 (28.49%) |
| CYTK | Cytokinetics, Incorporated | 66.80 (1.88%) |
| CTMX | CytomX Therapeutics, Inc | 1.65 (-2.08%) |
| DARE | Dar Bioscience, Inc. | 0.28 (-4.37%) |
| DBVT | DBV Technologies S.A | 0.69 (-2.42%) |
| DCPH | Deciphera Pharmaceuticals, Inc | 14.60 (-0.51%) |
| DNLI | Denali Therapeutics Inc | 15.55 (-3.48%) |
| DERM | Journey Medical Corp | 3.42 (-3.25%) |
| DMAC | DiaMedica Therapeutics Inc | 2.50 (3.31%) |
| DRRX | DURECT Corporation | 0.91 (7.55%) |
| DVAX | Dynavax Technologies Corporation | 11.44 (-2.76%) |
| EGRX | Eagle Pharmaceuticals, Inc | 4.58 (-3.98%) |
| EDAP | EDAP TMS S.A | 6.85 (-3.39%) |
| EDIT | Editas Medicine, Inc | 5.36 (-1.83%) |
| ECOR | electroCore, Inc | 5.98 (5.65%) |
| ENTA | Enanta Pharmaceuticals, Inc | 12.93 (-1.67%) |
| TNDM | Tandem Diabetes Care, Inc | 35.12 (0.41%) |
| NDRA | ENDRA Life Sciences Inc | 0.25 (0.08%) |
| EQ | Equillium, Inc | 1.80 (4.65%) |
| ESPR | Esperion Therapeutics, Inc | 2.12 (1.20%) |
| EPIX | ESSA Pharma Inc | 6.38 (-0.31%) |
| ETON | Eton Pharmaceuticals, Inc | 3.21 (-2.13%) |
| EVOK | Evoke Pharma, Inc | 0.43 (-2.37%) |
| EOLS | Evolus, Inc | 11.48 (-1.88%) |
| EXAS | Exact Sciences Corporation | 63.26 (-0.42%) |
| EXEL | Exelixis, Inc | 23.71 (1.82%) |
| EYEN | Eyenovia, Inc | 0.59 (8.68%) |
| EYPT | EyePoint Pharmaceuticals, Inc | 16.50 (-6.12%) |
| FATE | Fate Therapeutics, Inc | 4.31 (-5.07%) |
| FENC | Fennec Pharmaceuticals Inc | 9.07 (-1.84%) |
| FONR | FONAR Corporation | 16.10 (0.56%) |
| FBIO | Fortress Biotech, Inc | 1.78 (-1.38%) |
| GTHX | G1 Therapeutics, Inc | 3.98 (-5.01%) |
| GLPG | Galapagos NV | 28.78 (-2.28%) |
| GALT | Galectin Therapeutics Inc | 3.29 (-2.81%) |
| GLMD | Galmed Pharmaceuticals Ltd | 0.39 (6.59%) |
| GENE | Genetic Technologies Limited | 2.16 (-10.00%) |
| GNPX | Genprex, Inc | 2.32 (0.43%) |
| GERN | Geron Corporation | 3.57 (2.00%) |
| GILD | Gilead Sciences, Inc | 67.10 (0.10%) |
| GLYC | GlycoMimetics, Inc | 1.85 (1.09%) |
| GOSS | Gossamer Bio, Inc | 0.71 (-3.81%) |
| GRFS | Grifols, S.A | 6.39 (-1.31%) |
| GRTS | Gritstone Oncology, Inc | 0.82 (10.99%) |
| HALO | Halozyme Therapeutics, Inc | 39.12 (0.37%) |
| HBIO | Harvard Bioscience, Inc | 3.71 (-0.27%) |
| HSDT | Helius Medical Technologies, Inc | 4.82 (-1.63%) |
| HRTX | Heron Therapeutics, Inc | 2.66 (-5.00%) |
| HOOK | HOOKIPA Pharma Inc | 0.84 (10.20%) |
| HOTH | Hoth Therapeutics, Inc | 1.21 (1.68%) |
| ICLR | ICON Public Limited Company | 309.10 (0.86%) |
| IDYA | IDEAYA Biosciences, Inc | 39.89 (2.23%) |
| IDXX | IDEXX Laboratories, Inc | 494.23 (0.09%) |
| ILMN | Illumina, Inc | 122.81 (-1.33%) |
| ICCC | ImmuCell Corporation | 5.12 (1.39%) |
| IMMP | Immutep Limited | 2.59 (3.19%) |
| INCY | Incyte Corporation | 51.77 (0.23%) |
| IFRX | InflaRx N.V | 1.35 (-0.37%) |
| INVA | Innoviva, Inc | 15.16 (-0.07%) |
| INSM | Insmed Incorporated | 25.81 (2.14%) |
| NTLA | Intellia Therapeutics, Inc | 21.18 (-1.65%) |
| ITCI | Intra-Cellular Therapies, Inc | 73.17 (-1.13%) |
| IONS | Ionis Pharmaceuticals, Inc | 42.46 (1.48%) |
| IOVA | Iovance Biotherapeutics, Inc | 11.70 (-1.35%) |
| IRIX | IRIDEX Corporation | 2.99 (-1.32%) |
| IRWD | Ironwood Pharmaceuticals, Inc | 8.11 (-2.41%) |
| ITRM | Iterum Therapeutics plc | 1.52 (-3.80%) |
| JAGX | Jaguar Health, Inc | 0.17 (1.43%) |
| JAZZ | Jazz Pharmaceuticals plc | 108.33 (-1.23%) |
| KALA | Kala Pharmaceuticals, Inc | 6.61 (1.69%) |
| KALV | KalVista Pharmaceuticals, Inc | 10.39 (-7.31%) |
| KMDA | Kamada Ltd | 5.16 (1.18%) |
| KPTI | Karyopharm Therapeutics Inc | 1.10 (0.92%) |
| KNSA | Kiniksa Pharmaceuticals, Ltd | 17.85 (0.96%) |
| KRYS | Krystal Biotech, Inc | 158.84 (-1.97%) |
| KURA | Kura Oncology, Inc | 18.74 (0.05%) |
| LNTH | Lantheus Holdings, Inc | 65.23 (1.27%) |
| LPTX | Leap Therapeutics, Inc | 3.28 (2.50%) |
| LXRX | Lexicon Pharmaceuticals, Inc | 1.59 (-0.93%) |
| LFVN | LifeVantage Corporation | 6.15 (-3.98%) |
| LGND | Ligand Pharmaceuticals Incorporated | 70.83 (1.34%) |
| LPCN | Lipocine Inc | 4.51 (-6.04%) |
| LQDA | Liquidia Corporation | 12.55 (-3.09%) |
| LIVN | LivaNova PLC | 55.92 (1.64%) |
| LUNA | Luna Innovations Incorporated | 2.05 (-7.66%) |
| MGNX | MacroGenics, Inc | 15.72 (-3.14%) |
| MDGL | Madrigal Pharmaceuticals, Inc | 204.61 (-6.31%) |
| MNKD | MannKind Corporation | 4.18 (0.48%) |
| MRNS | Marinus Pharmaceuticals, Inc | 1.46 (1.04%) |
| MRKR | Marker Therapeutics, Inc | 4.43 (0.45%) |
| MASI | Masimo Corporation | 135.84 (-0.81%) |
| MNOV | MediciNova, Inc | 1.34 (0.75%) |
| MEDP | Medpace Holdings, Inc | 397.72 (-2.32%) |
| MEIP | MEI Pharma, Inc | 3.26 (-5.51%) |
| MACK | Merrimack Pharmaceuticals, Inc | 14.72 (-0.03%) |
| MRSN | Mersana Therapeutics, Inc | 2.90 (-9.81%) |
| MRUS | Merus N.V | 41.98 (2.84%) |
| MESO | Mesoblast Limited | 6.19 (3.17%) |
| MBOT | Microbot Medical Inc | 0.89 (0.76%) |
| NERV | Minerva Neurosciences, Inc | 2.48 (-1.98%) |
| MRNA | Moderna, Inc | 108.93 (0.96%) |
| MTEM | Molecular Templates, Inc | 1.55 (0.32%) |
| MBRX | Moleculin Biotech, Inc | 4.45 (-3.26%) |
| MORF | Morphic Holding, Inc | 27.71 (-3.62%) |
| MBIO | Mustang Bio, Inc | 0.35 (-2.70%) |
| MYGN | Myriad Genetics, Inc | 18.64 (0.24%) |
| NATR | Nature's Sunshine Products, Inc | 19.55 (-1.09%) |
| NKTR | Nektar Therapeutics | 1.40 (-1.76%) |
| NEOG | Neogen Corporation | 12.40 (0.73%) |
| NXTC | NextCure, Inc | 1.43 (-6.54%) |
| NBIX | Neurocrine Biosciences, Inc | 138.96 (-0.81%) |
| NVAX | Novavax, Inc | 4.15 (-0.95%) |
| NCNA | NuCana plc | 3.84 (-5.42%) |
| OCUL | Ocular Therapeutix, Inc | 4.64 (-7.20%) |
| OMER | Omeros Corporation | 3.06 (-1.13%) |
| ONCY | Oncolytics Biotech Inc | 1.06 (0.00%) |
| OPK | OPKO Health, Inc | 1.23 (-2.00%) |
| OPTN | OptiNose, Inc | 0.92 (-4.59%) |
| ORMP | Oramed Pharmaceuticals Inc | 2.38 (1.28%) |
| ORGO | Organogenesis Holdings Inc | 3.00 (0.50%) |
| ONVO | Organovo Holdings, Inc | 1.00 (0.50%) |
| ORGS | Orgenesis Inc | 0.50 (-3.66%) |
| OTLK | Outlook Therapeutics, Inc | 8.20 (0.00%) |
| OVID | Ovid Therapeutics Inc | 3.17 (-0.78%) |
| PACB | Pacific Biosciences of California, Inc | 1.36 (-7.48%) |
| PCRX | Pacira BioSciences, Inc | 25.92 (-3.32%) |
| PAHC | Phibro Animal Health Corporation | 12.59 (-7.49%) |
| PHIO | Phio Pharmaceuticals Corp | 0.67 (-4.11%) |
| PIRS | Pieris Pharmaceuticals, Inc | 11.72 (-2.66%) |
| PRPO | Precipio, Inc | 6.10 (-0.81%) |
| PRPH | ProPhase Labs, Inc | 5.12 (-0.78%) |
| PRQR | ProQR Therapeutics N.V | 2.00 (-0.99%) |
| PTGX | Protagonist Therapeutics, Inc | 25.70 (-4.30%) |
| PRTA | Prothena Corporation plc | 20.59 (0.17%) |
| PTCT | PTC Therapeutics, Inc | 25.19 (-0.87%) |
| PBYI | Puma Biotechnology, Inc | 4.83 (-5.75%) |
| QTRX | Quanterix Corporation | 16.07 (-0.19%) |
| QDEL | Quidel Corporation | 40.81 (1.01%) |
| RDHL | RedHill Biopharma Ltd | 0.41 (-3.24%) |
| REGN | Regeneron Pharmaceuticals, Inc | 906.82 (-0.06%) |
| RGNX | REGENXBIO Inc | 16.05 (0.94%) |
| RGLS | Regulus Therapeutics Inc | 2.23 (-1.33%) |
| RGEN | Repligen Corporation | 167.81 (-2.03%) |
| REPL | Replimune Group, Inc | 6.32 (-1.64%) |
| RVNC | Revance Therapeutics, Inc | 3.57 (-2.46%) |
| RYTM | Rhythm Pharmaceuticals, Inc | 39.80 (-0.50%) |
| RIGL | Rigel Pharmaceuticals, Inc | 1.13 (-1.32%) |
| RCKT | Rocket Pharmaceuticals, Inc | 23.64 (-0.13%) |
| RMTI | Rockwell Medical, Inc | 1.46 (-4.58%) |
| SAGE | Sage Therapeutics, Inc | 14.00 (8.11%) |
| SGMO | Sangamo Therapeutics, Inc | 0.49 (-5.09%) |
| SRPT | Sarepta Therapeutics, Inc | 124.31 (6.13%) |
| SVRA | Savara Inc | 4.25 (-9.49%) |
| SRRK | Scholar Rock Holding Corporation | 14.11 (-4.60%) |
| SCPH | scPharmaceuticals Inc | 4.50 (-2.39%) |
| SCYX | SCYNEXIS, Inc | 1.50 (-3.55%) |
| SLS | SELLAS Life Sciences Group, Inc | 1.54 (-5.52%) |
| MCRB | Seres Therapeutics, Inc | 0.73 (-3.99%) |
| SWAV | ShockWave Medical, Inc | 328.86 (0.10%) |
| SIGA | SIGA Technologies, Inc | 8.66 (-1.14%) |
| SLNO | Soleno Therapeutics, Inc | 39.30 (-2.09%) |
| SLGL | Sol-Gel Technologies Ltd | 0.92 (-4.30%) |
| SLDB | Solid Biosciences Inc | 8.75 (-3.95%) |
| SNGX | Soligenix, Inc | 0.39 (-3.75%) |
| SNOA | Sonoma Pharmaceuticals, Inc | 0.15 (-2.52%) |
| SPRO | Spero Therapeutics, Inc | 1.41 (-1.74%) |
| SMMT | Summit Therapeutics Inc | 3.60 (-3.35%) |
| SUPN | Supernus Pharmaceuticals, Inc | 30.30 (1.15%) |
| STRO | Sutro Biopharma, Inc | 3.46 (-6.99%) |
| SNDX | Syndax Pharmaceuticals, Inc | 20.80 (-0.81%) |
| SYBX | Synlogic, Inc | 1.90 (-0.52%) |
| SYRS | Syros Pharmaceuticals, Inc | 5.05 (-1.65%) |
| TENX | Tenax Therapeutics, Inc | 3.51 (-0.57%) |
| TGTX | TG Therapeutics, Inc | 14.00 (-1.75%) |
| TXMD | TherapeuticsMD, Inc | 1.88 (-0.79%) |
| TBPH | Theravance Biopharma, Inc | 9.17 (-0.54%) |
| TTNP | Titan Pharmaceuticals, Inc | 7.05 (-2.22%) |
| TNXP | Tonix Pharmaceuticals | 0.16 (1.66%) |
| TCON | TRACON Pharmaceuticals, Inc | 1.88 (1.62%) |
| TRVN | Trevena, Inc | 0.37 (-4.38%) |
| TWST | Twist Bioscience Corporation | 30.75 (-2.38%) |
| RARE | Ultragenyx Pharmaceutical Inc | 44.23 (-1.95%) |
| QURE | uniQure N.V | 4.57 (-3.79%) |
| UTHR | United Therapeutics Corporation | 237.18 (1.16%) |
| URGN | UroGen Pharma Ltd | 14.21 (-2.20%) |
| VNDA | Vanda Pharmaceuticals Inc | 4.57 (-1.30%) |
| VXRT | Vaxart, Inc | 0.71 (-5.41%) |
| VBIV | VBI Vaccines Inc | 0.59 (-3.16%) |
| VSTM | Verastem, Inc | 9.32 (-3.02%) |
| VCEL | Vericel Corporation | 46.12 (-0.65%) |
| VRNA | Verona Pharma plc | 15.21 (-2.44%) |
| VRCA | Verrica Pharmaceuticals Inc | 6.80 (-0.66%) |
| VRTX | Vertex Pharmaceuticals Incorporated | 400.75 (-1.03%) |
| VERU | Veru Inc | 1.32 (3.92%) |
| VKTX | Viking Therapeutics, Inc | 65.11 (0.28%) |
| VTGN | VistaGen Therapeutics, Inc | 4.75 (-1.66%) |
| VYGR | Voyager Therapeutics, Inc | 7.59 (-0.78%) |
| VTVT | vTv Therapeutics Inc | 25.39 (4.36%) |
| WVE | Wave Life Sciences Ltd | 5.01 (-1.38%) |
| XBIT | XBiotech Inc | 8.07 (-1.28%) |
| XNCR | Xencor, Inc | 19.05 (3.70%) |
| XENE | Xenon Pharmaceuticals Inc | 39.55 (-3.75%) |
| XERS | Xeris Pharmaceuticals, Inc | 1.77 (-0.56%) |
| XOMA | XOMA Corporation | 25.88 (-0.80%) |
| XTLB | XTL Biopharmaceuticals Ltd | 2.49 (-3.86%) |
| YMAB | Y-mAbs Therapeutics, Inc | 15.30 (-0.26%) |
| ZLAB | Zai Lab Limited | 15.64 (3.44%) |
| GH | Guardant Health, Inc | 18.09 (4.33%) |
| CVS | CVS Health Corporation | 67.72 (-1.15%) |
| INMD | InMode Ltd | 17.38 (0.03%) |
| DVA | DaVita Inc | 132.78 (-0.84%) |
| NEO | NeoGenomics, Inc | 14.05 (-0.78%) |
| VNRX | VolitionRx Limited | 0.81 (-5.29%) |
| ISRG | Intuitive Surgical, Inc | 374.85 (-0.59%) |
| EBS | Emergent BioSolutions Inc | 2.18 (-4.80%) |
| BMY | Bristol-Myers Squibb Company | 48.84 (-0.30%) |
| NBY | NovaBay Pharmaceuticals, Inc | 0.08 (-1.95%) |
| CAH | Cardinal Health, Inc | 103.53 (0.15%) |
| LLY | Eli Lilly and Company | 731.61 (-1.89%) |
| TEVA | Teva Pharmaceutical Industries Limited | 13.01 (0.00%) |
| MRK | Merck & Co. | 126.95 (0.06%) |
| PFE | Pfizer Inc | 26.25 (-0.25%) |
| APDN | Applied DNA Sciences, Inc | 0.25 (-14.59%) |
| ABBV | AbbVie Inc | 167.91 (-0.96%) |
| ETNB | 89bio, Inc | 8.59 (-3.70%) |
| NVCR | NovoCure Limited | 12.32 (2.24%) |
| NVS | Novartis | 98.39 (1.14%) |
| RDY | Dr. Reddy's Laboratories Limited | 70.97 (-0.73%) |
| APRE | Aprea Therapeutics, Inc | 5.71 (7.33%) |
| TELA | TELA Bio, Inc | 4.46 (-0.22%) |
| GRTX | Galera Therapeutics, Inc | 0.18 (-6.13%) |
| RAPT | RAPT Therapeutics, Inc | 7.91 (-1.19%) |
| TFFP | TFF Pharmaceuticals, Inc | 3.04 (0.50%) |
| RLMD | Relmada Therapeutics, Inc | 3.85 (-1.53%) |
| INO | Inovio Pharmaceuticals, Inc | 10.18 (-1.88%) |
| MNPR | Monopar Therapeutics Inc | 0.63 (-3.08%) |
| IGMS | IGM Biosciences, Inc | 7.92 (2.86%) |
| IMAB | I-Mab | 1.80 (0.28%) |
| STOK | Stoke Therapeutics, Inc | 11.65 (3.56%) |
| ANVS | Annovis Bio, Inc | 12.67 (6.65%) |
| ARQT | Arcutis Biotherapeutics, Inc | 8.76 (0.23%) |
| RVMD | Revolution Medicines, Inc | 35.59 (-1.85%) |
| FULC | Fulcrum Therapeutics, Inc | 7.26 (-2.35%) |
| MIRM | Mirum Pharmaceuticals, Inc | 24.03 (-1.60%) |
| SWTX | SpringWorks Therapeutics, Inc | 43.30 (-1.59%) |
| ZNTL | Zentalis Pharmaceuticals, Inc | 11.76 (-6.48%) |
| LYRA | Lyra Therapeutics, Inc | 5.23 (0.38%) |
| MIST | Milestone Pharmaceuticals Inc | 1.67 (-1.76%) |
| ADCT | ADC Therapeutics | 4.78 (-3.92%) |
| ORIC | ORIC Pharmaceuticals, Inc | 8.09 (-7.75%) |
| LEGN | Legend Biotech Corporation | 45.12 (-4.91%) |
| RPRX | Royalty Pharma plc | 27.96 (0.52%) |
| FUSN | Fusion Pharmaceuticals Inc | 21.41 (-0.05%) |
| GBIO | Generation Bio Co | 2.99 (-8.28%) |
| NRIX | Nurix Therapeutics, Inc | 13.76 (-2.62%) |
| INZY | Inozyme Pharma, Inc | 4.41 (0.23%) |
| ANNX | Annexon, Inc | 4.44 (0.00%) |
| CYCN | Cyclerion Therapeutics, Inc | 3.11 (12.27%) |
| PHGE | BiomX Inc | 0.33 (-5.51%) |
| CVAC | CureVac N.V | 2.50 (-3.65%) |
| HRMY | Harmony Biosciences Holdings, Inc | 29.21 (1.25%) |
| TARA | Protara Therapeutics, Inc | 2.81 (-6.33%) |
| PMVP | PMV Pharmaceuticals, Inc | 1.70 (-6.09%) |
| TARS | Tarsus Pharmaceuticals, Inc | 32.80 (-2.70%) |
| ALGS | Aligos Therapeutics, Inc | 0.82 (-0.39%) |
| AVIR | Atea Pharmaceuticals, Inc | 3.71 (-0.67%) |
| GLTO | Galecto, Inc | 0.65 (-7.21%) |
| ONCT | Oncternal Therapeutics, Inc | 8.76 (2.28%) |
| PRAX | Praxis Precision Medicines, Inc | 50.99 (4.40%) |
| VRPX | Virpax Pharmaceuticals, Inc | 3.19 (1.27%) |
| RPHM | Reneo Pharmaceuticals, Inc. Common Stock | 1.68 (0.00%) |
| CGEM | Cullinan Oncology, Inc | 18.87 (13.20%) |
| VERA | Vera Therapeutics Inc | 39.95 (1.09%) |
| CLNN | Clene Inc | 0.34 (0.69%) |
| KTRA | Kintara Therapeutics, Inc | 0.14 (3.54%) |
| DAWN | Day One Biopharmaceuticals Inc | 15.20 (-8.68%) |
| CNTA | Centessa Pharmaceuticals plc | 9.46 (0.64%) |
| NRXP | NRX Pharmaceuticals Inc | 3.10 (1.80%) |
| ABOS | Acumen Pharmaceuticals Inc | 3.17 (0.47%) |
| ACXP | Acurx Pharmaceuticals Inc | 1.97 (-3.68%) |
| KPRX | Kiora Pharmaceuticals, Inc. | 0.50 (-13.03%) |
| KRON | Kronos Bio Inc | 0.96 (1.52%) |
| PCSA | Processa Pharmaceuticals Inc | 1.64 (2.50%) |
| NVCT | Nuvectis Pharma Inc | 6.71 (1.90%) |
| SBFM | Sunshine Biopharma Inc | 0.95 (-21.07%) |
| BLTE | Belite Bio, Inc | 37.23 (0.62%) |
| MAIA | MAIA Biotechnology, Inc. | 2.70 (9.76%) |
| THRD | Third Harmonic Bio, Inc. | 11.36 (2.81%) |
| RNAZ | TransCode Therapeutics Inc | 0.45 (-1.72%) |
| OCUP | Ocuphire Pharma Inc | 1.52 (-1.30%) |
| SPRC | SciSparc Ltd | 1.21 (-1.63%) |
| MIRA | MIRA Pharmaceuticals, Inc. | 0.87 (-0.92%) |